Status:
COMPLETED
Procalcitonin Test for Differentiation of the Cause of Pneumonia
Lead Sponsor:
National Cancer Center, Korea
Conditions:
Procalcitonin
Pneumonia
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to evaluate the usefulness of procalcitonin test for differentiation of the cause of pneumonia in patients with cancer.
Detailed Description
Serum procalcitonin test is currently used as the biomarker for bacterial infection. Especially, procalcitonin test has been reported to be helpful in differentiating bacterial pneumonia from viral pn...
Eligibility Criteria
Inclusion
- Age greater than 18 years
- Patients who have symptoms and suspected imaging findings compatible with pneumonia
Exclusion
- Patients who have been treated with antibiotics or steroid therapy.
Key Trial Info
Start Date :
January 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
649 Patients enrolled
Trial Details
Trial ID
NCT03350802
Start Date
January 1 2014
End Date
June 30 2020
Last Update
September 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Respiratory Clinic, National Cancer Center
Goyang-si, Gyeonggi-do, South Korea, 410-769